title: Hepatitis E.
abstract: Hepatitis E has a world-wide distribution and causes substantial morbidity and mortality in some developing countries, particularly among pregnant women. Hepatitis E virus (HEV) has recently been cloned and sequenced, and new diagnostic tests have been developed. These tests have been used to begin to characterize the natural history and epidemiological features of HEV infection. Experimental vaccines have also been developed that offer the potential to prevent hepatitis E. However, much remains to be learned about HEV, including the mechanisms of transmission, the reservoir(s) of the virus, and the natural history of protective immunity in order to develop effective strategies to prevent this disease.
authors.affiliation: Hepatitis Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
authors.forename: E E
authors.initials: EE
authors.lastname: Mast
authors.forename: M A
authors.initials: MA
authors.lastname: Purdy
authors.forename: K
authors.initials: K
authors.lastname: Krawczynski
mesh_terms: D000328:Adult; D005260:Female; D016751:Hepatitis E / Q000453:epidemiology / Q000635:transmission; D016752:Hepatitis E virus; D006801:Humans; D008297:Male; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000821:virology; D012307:Risk Factors